[1]韩 莉,徐红艳,王 立,等.耐药肺结核患者血清可溶性白细胞分化抗原14、降钙素原、白介素-22水平变化及对抗结核疗效的预测价值[J].陕西医学杂志,2023,52(11):1535-1540.[doi:DOI:10.3969/j.issn.1000-7377.2023.11.018]
　HAN Li,XU Hongyan,WANG Li,et al.Changes of serum soluble CD14,procalcitonin and interleukin-22 levels in drug-resistant pulmonary tuberculosis and their value in predicting antituberculosis efficacy[J].,2023,52(11):1535-1540.[doi:DOI:10.3969/j.issn.1000-7377.2023.11.018]
点击复制

耐药肺结核患者血清可溶性白细胞分化抗原14、降钙素原、白介素-22水平变化及对抗结核疗效的预测价值
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
52
期数:
2023年11期
页码:
1535-1540
栏目:
临床研究
出版日期:
2023-11-05

文章信息/Info

Title:
Changes of serum soluble CD14,procalcitonin and interleukin-22 levels in drug-resistant pulmonary tuberculosis and their value in predicting antituberculosis efficacy
作者:
韩 莉; 徐红艳; 王 立; 高 瑜
(陕西省结核病防治院,陕西 西安 710100)
Author(s):
HAN Li; XU Hongyan; WANG Li; GAO Yu
(Shaanxi Provincial Institute of Tuberculosis,Xi'an 710100,China)
关键词:
肺结核;  耐药性;  可溶性白细胞分化抗原14;  降钙素原;  白介素-22;  相关性
Keywords:
Pulmonary tuberculosis;  Drug resistance;  Soluble leukocyte differentiation antigen 14;  Procalcitonin;  Interleukin-22;  Correlation
分类号:
R 521
DOI:
DOI:10.3969/j.issn.1000-7377.2023.11.018
文献标志码:
A
摘要:
目的:探究耐药肺结核患者血清可溶性白细胞分化抗原14(sCD14)、降钙素原(PCT)、白介素-22(IL-22)水平变化,并分析其对抗结核疗效的预测价值。方法:选取196例肺结核患者为研究对象,根据耐药情况分为耐药组(n=97)和非耐药组(n=99)。比较两组血清sCD14、PCT、IL-22水平,比较耐药组不同临床特征患者血清各指标水平,分析其与耐药肺结核临床特征的相关性。耐药组均根据结核菌培养及药敏试验结果进行规范化抗结核治疗6个月,对比转阴患者、未转阴患者治疗前、治疗1、3、6个月后血清sCD14、PCT、IL-22水平及变化值。分析治疗前后血清指标水平变化值与抗结核疗效的关系及其预测抗结核疗效的价值。结果:耐药组血清sCD14、PCT、IL-22水平高于非耐药组高(均P<0.05); 耐药组血清各指标水平与肺部空洞、耐药程度、病情程度呈正相关(均P<0.05); 未转阴患者治疗前、治疗1、3、6个月后血清各指标水平高于转阴患者,其水平变化值低于转阴患者(均P<0.05); 血清各指标变化值与抗结核疗效呈正相关(P<0.05); 治疗3个月后血清各指标变化值联合预测抗结核疗效的AUC大于治疗1个月后血清各指标变化值联合预测的AUC(P<0.05)。结论:耐药肺结核患者血清sCD14、PCT、IL-22水平升高,且与病情严重程度、抗结核疗效有关,联合检测其水平对抗结核疗效具有一定预测价值。
Abstract:
Objective:To investigate the serum levels of soluble leukocyte differentiation antigen 14(sCD14),procalcitonin(PCT)and interleukin-22(IL-22)in patients with drug-resistant tuberculosis,and to analyze the predictive value of their anti-tuberculosis efficacy.Methods:A total of 196 patients with pulmonary tuberculosis were selected as research objects,and divided into drug-resistant group(97 cases)and non-drug-resistant group(99 cases)according to drug resistance.Serum levels of sCD14,PCT and IL-22 were compared between the two groups.The serum levels of different clinical characteristics of patients in drug-resistant group were compared,and the correlation between them and the clinical characteristics of drug-resistant pulmonary tuberculosis was analyzed.The drug-resistant group received standardized anti-tuberculosis therapy for 6 months according to the results of tuberculosis culture and drug sensitivity test.Serum levels and changes of sCD14,PCT and IL-22 in patients with negative conversion and patients without negative conversion were compared before treatment,and 1,3 and 6 months after treatment.The relationship between the change of serum indexes levels before and after treatment and the antituberculous effect and the value of predicting the antituberculous effect were analyzed.Results:The serum levels of sCD14,PCT and IL-22 in drug-resistant group were higher than those in non-drug-resistant group(all P<0.05).The levels of serum indexes in drug resistant group were positively correlated with pulmonary cavity,drug resistance degree and disease degree(all P<0.05).The levels of serum indexes in patients without conversion to negative were higher than those in patients with conversion to negative before treatment,and 1,3 and 6 months after treatment,and the change values were lower than those in patients with conversion to negative(all P<0.05).The changes of serum indexes were positively correlated with the antituberculosis efficacy(all P<0.05).The AUC combined with the changes of serum indexes after 3 months of treatment was greater than the AUC combined with the changes of serum indexes after 1 month of treatment(P<0.05).Conclusion:The serum levels of sCD14,PCT and IL-22 in patients with drug-resistant tuberculosis are increased,which is related to the severity of the disease and the anti-tuberculosis efficacy.The combined detection of their levels has certain predictive value for the anti-tuberculosis efficacy.

参考文献/References:

[1] 惠立本,解建毅,王 立,等.超声引导颈部淋巴结穿刺活检在肺结核患者继发颈部淋巴结结核中的诊断价值[J].陕西医学杂志,2022,51(7):890-893.
[2] 康冠楠,党 萍,马清艳,等.芪参益肺汤联合康复新液治疗老年肺结核疗效及对患者肺功能、免疫功能的影响[J].陕西中医,2021,42(10):1393-1396.
[3] Pillay S,Steingart KR,Davies GR,et al.Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid,fluoroquinolones,ethionamide and amikacin[J].Cochrane Database Syst Rev,2022,5(5):14841-14851.
[4] 胡慧婷,袁静芝,史清海,等.血清sCD14、HMGB1联合检测在肺部感染疾病中的临床诊断价值[J].国际检验医学杂志,2020,41(3):270-273.
[5] Ding RD,Zhang HJ.Effect of linezolid on serum PCT,ESR and CRP in patients with pulmonary tuberculosis and pneumonia[J].Medicine(Baltimore),2018,97(37):12177-12187.
[6] Imperiale BR,García A,Minotti A,et al.Th22 response induced by mycobacterium tuberculosis strains is closely related to severity of pulmonary lesions and bacillary load in patients with multi-drug-resistant tuberculosis[J].Clin Exp Immunol,2021,203(2):267-280.
[7] 张培元.肺结核诊断和治疗指南[J].中华结核和呼吸杂志,2001,24(2):70-74.
[8] 黄麦玲,高孟秋.WHO 2014年版《耐药结核病规划管理指南伙伴手册》系列解读之八(单耐药和多耐药结核病的治疗管理)[J].中国防痨杂志,2015,37(7):802-804.
[9] 李 蓓,张冬平,张泽波.TGF-β、IFN-γ、IL-10与多药联合治疗肺结核产生耐药性和疗效的相关性探讨[J].东南大学学报:医学版,2022,41(1):114-120.
[10] 吴桂辉,黄 涛,罗 槑,等.不同类型肺结核患者外周血维生素D与抗菌肽LL-37表达水平的研究[J].中国防痨杂志,2019,41(2):190-194.
[11] 梁建琴.耐药结核病的规范化治疗策略[J].临床药物治疗杂志,2018,16(4):14-17.
[12] Cho HJ,Lim YJ,Kim J,et al.Different macrophage polarization between drug-susceptible and multidrug-resistant pulmonary tuberculosis[J].BMC Infect Dis,2020,20(1):81-91.
[13] 李小月,张艳丽,曹 光,等.黄芪注射液辅助治疗肺结核合并糖尿病疗效及作用机制研究[J].陕西中医,2020,41(4):487-489.
[14] 杨元利,张永峰,窦权利.老年肺结核病130例临床分析[J].陕西医学杂志,2019,48(12):1691-1693.
[15] Galliera E,Massaccesi L,Yu L,et al.SCD14-ST and new generation inflammatory biomarkers in the prediction of COVID-19 outcome[J].Biomolecules,2022,12(6):826-836.
[16] Wang K,Li L,Wang Y,et al.Effect of Baihe Gujin decoction combined with Shengmai powder on the expression of IL-1β and IL-1Ra in peripheral blood CD14+ monocytes from patients with pulmonary tuberculosis[J].Cell Mol Biol,2022,68(2):60-63.
[17] Gradek-Kwinta E,Czyzycki M,Lopatkiewicz AM,et al.Lipopolysaccharide binding protein and sCD14 as risk markers of stroke-associated pneumonia[J].J Neuroimmunol,2021,354(1):577532-577542.
[18] Li Y,Min L,Zhang X.Usefulness of procalcitonin(PCT),C-reactive protein(CRP)and white blood cell(WBC)levels in the differential diagnosis of acute bacterial,viral,and mycoplasmal respiratory tract infections in children[J].BMC Pulm Med,2021,21(1):386-396.
[19] 苏 琦.多重耐药肺结核患者血清PCT和sTREM-1水平与其临床预后的相关性[J].现代诊断与治疗,2020,31(7):1117-1118.
[20] 江颖仪,李德宪,劳穗华,等.血清淀粉样蛋白A、降钙素原、超敏C反应蛋白检测对肺结核合并肺炎的诊断价值[J].南方医科大学学报,2021,41(3):453-458.
[21] Wang J,Ren S,Liu Y,et al.Carcinoid tumorlets co-existing with chronic pulmonary inflammatory processes:Imaging findings and histological appearances[J].Med Sci Monit,2020,26(1):926014-926024.
[22] Alcorn JF.IL-22 plays a critical role in maintaining epithelial integrity during pulmonary infection[J].Front Immunol,2020,11(1):1160-1170.
[23] Tripathi D,Radhakrishnan RK,Sivangala TR,et al.IL-22 produced by type 3 innate lymphoid cells(ILC3s)reduces the mortality of type 2 diabetes mellitus(T2DM)mice infected with Mycobacterium tuberculosis[J].PLoS Pathog,2019,15(12):1008140-1008150.
[24] Yang E,Yang R,Guo M,et al.Multidrug-resistant tuberculosis(MDR-TB)strain infection in macaques results in high bacilli burdens in airways,driving broad innate/adaptive immune responses[J].Emerg Microbes Infect,2018,7(1):207-217.
[25] Jiang Q,Yang G,Xiao F,et al.Role of Th22 cells in the pathogenesis of autoimmune diseases[J].Front Immunol,2021,12(1):688066-688076.

相似文献/References:

[1]迟 旭,漆 沄△,陈 娟,等.初次抗结核治疗诱发药物性肝损伤临床特点及发病危险因素的Logistic回归分析[J].陕西医学杂志,2019,(1):67.
[2]李晓晓,梁亚萍,赵 涛,等.结核病患者422例耐药情况调查研究*[J].陕西医学杂志,2020,49(2):250.
　LI Xiaoxiao,LIANG Yaping,ZHAO Tao,et al.Analysis of drug resistance in 422 hospitalized patients with tuberculosis[J].,2020,49(11):250.
[3]刘 莉,李 晋,马 云,等.肺结核348例耐药情况调查及影响因素分析[J].陕西医学杂志,2021,50(5):626.[doi:DOI:10.3969/j.issn.1000-7377.2021.05.028]
　LIU Li,LI Jin,MA Yun,et al.Investigation of drug resistance in 348 cases of pulmonary tuberculosis and its influencing factors[J].,2021,50(11):626.[doi:DOI:10.3969/j.issn.1000-7377.2021.05.028]
[4]庞 晖,王 丽,李 娜,等.活动期肺结核患者血清淀粉样蛋白4、凝溶胶蛋白检测及临床意义[J].陕西医学杂志,2021,50(10):1286.[doi:DOI:10.3969/j.issn.1000-7377.2021.10.028]
[5]杜 晶,张竹青,马春梅,等.老年急性呼吸衰竭合并肺部感染患者病原菌分布特点、耐药性及血清白介素-6、白介素-10水平变化临床意义[J].陕西医学杂志,2023,52(10):1354.[doi:DOI:10.3969/j.issn.1000-7377.2023.10.015]
　DU Jing,ZHANG Zhuqing,MA Chunmei,et al.Distribution and drug resistance of pathogenic bacteria in elderly patients with acute respiratory failure complicated with pulmonary infection and clinical significance of changes in serum IL-6 and IL-10 levels[J].,2023,52(11):1354.[doi:DOI:10.3969/j.issn.1000-7377.2023.10.015]
[6]陈 宇,赵 雅,王 林.眼表定植菌群分布特征及常见菌耐药性分析[J].陕西医学杂志,2023,52(10):1423.[doi:DOI:10.3969/j.issn.1000-7377.2023.10.032]
　CHEN Yu,ZHAO Ya,WANG Lin.Distribution characteristics of common bacteria colonizing ocular surface and drug resistance analysis[J].,2023,52(11):1423.[doi:DOI:10.3969/j.issn.1000-7377.2023.10.032]
[7]江海燕,杨 敏,江 雪,等.结核性胸膜炎合并肺部感染病原菌特点、耐药性及影响因素分析[J].陕西医学杂志,2023,52(12):1740.[doi:DOI:10.3969/j.issn.1000-7377.2023.12.025]
　JIANG Haiyan,YANG Min,JIANG Xue,et al.Characteristics,drug resistance and influencing factors of pathogenic bacteria in tuberculous pleuritis complated with pulmonary infection[J].,2023,52(11):1740.[doi:DOI:10.3969/j.issn.1000-7377.2023.12.025]
[8]符梦婕,张 剑,李秋忆,等.长链非编码RNA淋巴细胞白血病缺失基因2/微小RNA-30c-5p/丝裂原活化蛋白激酶1轴在食管癌细胞紫杉醇耐药中的作用机制实验研究[J].陕西医学杂志,2024,(9):1155.[doi:DOI:10.3969/j.issn.1000-7377.2024.09.001]
　FU Mengjie,ZHANG Jian,LI Qiuyi,et al.Mechanism of lncRNA DLEU2/miR-30c-5p/MAPK1 axis in paclitaxel resistance in esophageal cancer cells[J].,2024,(11):1155.[doi:DOI:10.3969/j.issn.1000-7377.2024.09.001]
[9]冯敏娟,蔡东阁,李 虹.转录因子7-like 2在宫颈癌中表达水平及其与顺铂化疗敏感性关系研究[J].陕西医学杂志,2024,(10):1335.[doi:DOI:10.3969/j.issn.1000-7377.2024.10.008]
　FENG Minjuan,CAI Dongge,LI Hong.Expression level of transcription factor 7-like 2 in cervical cancer and its relationship with cisplatin chemotherapy sensitivity[J].,2024,(11):1335.[doi:DOI:10.3969/j.issn.1000-7377.2024.10.008]
[10]刘 彪.血清微小RNA-27a、微小RNA-147、前列腺素E2水平与肺结核患者病情严重程度的关系研究[J].陕西医学杂志,2025,54(4):510.[doi:DOI:10.3969/j.issn.1000-7377.2025.04.015]

备注/Memo

备注/Memo:
基金项目:陕西省重点研发计划项目(2020SF-105)
更新日期/Last Update: 2023-11-06